Philippe Halfon

President and Founder

Pr Philippe Halfon (MD, PhD) has created many biotech companies. Today President and Founder of Alphabio, and the Head of Internal Medecine at the European Hospital, in Marseille, he has a deep experience in infectious diseases, especially in HCV, HBV and HIV, and in liver diseases. As a renowned physician in HCV, he uses his expertise as a founder to lead Genoscience Pharma since its creation in 2001.

Eric Raymond

Chief Medical Officer

Pr Eric Raymond (MD, PhD) is consultant, head of medical oncology at the Paris Saint-Joseph Hospital. He is board certified MD specialized in medical oncology and obtained a PhD degree in cellular and molecular biology, working on preclinical mechanisms of action and combinations of several novel anticancer drugs.
Over more than 10 years of experience as a chair of oncology in France and Switzerland, Eric Raymond developed in medical and research skill in patient care, oncology teaching, research, regulatory requirement, management, and team building. Eric Raymond specialized in various areas of drug development focusing on translational laboratory research and early clinical trials focusing on drugs and therapeutics with novel mechanisms of action. Eric Raymond developed a large number of academic- and industry-sponsored projects both in the lab and the clinic. Current focus is related to bridge preclinical and translational data to clinical applications to accelerate novel drug positioning both for safety and efficacy.

Sylvie Delpy

Regulatory Affairs Director

With more than 30-year experience in Regulatory Affairs, Sylvie successfully lead Genoscience Pharma in its regulatory submission in US (IND obtained), Belgium (CTA obtained) and France (CTA obtained) to competent authorities and ethics committee.

Cyrille Drouot

Chemistry Manufaturing Control Officer

Cyrille Drouot (PhD) has 17 years of experience in Chemical Manufacturing and Control through new chemical entities developments (Trophos – Olesoxime; Nicox - Naproxcinod) associated with successful clinical trials and IND/IMPD, NDA submissions. Then Cyrille. Drouot joined Minakem, one of the European CMO leaders, during 4 years as Quality and Regulatory Director, where he managed CEP and DMF submissions of APIs and quality strategy, over 3 manufacturing sites (FDA approved).